Clinical trial
Genetic Measurements in Blood Cells of Children Taking Adderall or…
NCT00341029 · National Institute of Environmental Health Sciences (NIEHS), NIH · Completed
Key facts
| NCT number | NCT00341029 |
|---|---|
| Title | Genetic Measurements in Blood Cells of Children Taking Adderall or Methylphenidate |
| Official title | Measurement of Cytogenetic Endpoints in Lymphocytes of Children Diagnosed With Attention Deficit/Hyperactivity Disorder (ADHD) and Treated With Methylphenidate or Adderall |
| Lead sponsor | National Institute of Environmental Health Sciences (NIEHS), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Attention Deficit Hyperactivity Disorder, ADHD |
| Enrollment | 84 |
| Start date | Dec 7, 2005 |
| Primary completion | Sep 30, 2007 |
| Completion | Sep 30, 2007 |
| First posted | Jun 21, 2006 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: